As of 2025-12-21, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 66.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.19 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 22.8%.
The range of the Relative Valuation is 55.72 - 103.73 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 35.0x | 25.2x |
| Forward P/E multiples | 18.8x - 20.5x | 19.7x |
| Fair Price | 55.72 - 103.73 | 66.53 |
| Upside | 2.8% - 91.4% | 22.8% |
| Date | P/E |
| 2025-12-19 | 18.26 |
| 2025-12-18 | 17.97 |
| 2025-12-17 | 18.05 |
| 2025-12-16 | 18.28 |
| 2025-12-15 | 18.30 |
| 2025-12-12 | 17.66 |
| 2025-12-11 | 17.26 |
| 2025-12-10 | 17.26 |
| 2025-12-09 | 17.07 |
| 2025-12-08 | 17.42 |
| 2025-12-05 | 17.58 |
| 2025-12-04 | 17.51 |
| 2025-12-03 | 17.18 |
| 2025-12-02 | 16.26 |
| 2025-12-01 | 16.58 |
| 2025-11-28 | 16.58 |
| 2025-11-26 | 16.60 |
| 2025-11-25 | 16.53 |
| 2025-11-24 | 16.10 |
| 2025-11-21 | 15.59 |
| 2025-11-20 | 15.48 |
| 2025-11-19 | 15.43 |
| 2025-11-18 | 15.86 |
| 2025-11-17 | 15.78 |
| 2025-11-14 | 15.72 |
| 2025-11-13 | 16.39 |
| 2025-11-12 | 16.54 |
| 2025-11-11 | 16.42 |
| 2025-11-10 | 15.93 |
| 2025-11-07 | 15.74 |
| 2025-11-06 | 15.72 |
| 2025-11-05 | 15.66 |
| 2025-11-04 | 15.37 |
| 2025-11-03 | 15.51 |
| 2025-10-31 | 15.53 |
| 2025-10-30 | 15.38 |
| 2025-10-29 | 14.36 |
| 2025-10-28 | 14.43 |
| 2025-10-27 | 14.62 |
| 2025-10-24 | 14.77 |
| 2025-10-23 | 14.77 |
| 2025-10-22 | 14.96 |
| 2025-10-21 | 15.01 |
| 2025-10-20 | 14.69 |
| 2025-10-17 | 14.71 |
| 2025-10-16 | 14.62 |
| 2025-10-15 | 14.70 |
| 2025-10-14 | 14.76 |
| 2025-10-13 | 14.67 |
| 2025-10-10 | 14.82 |